Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center of the University of Pennsylvania, has been honored with the 2025 Jill Rose Award for Scientific Excellence from the Breast Cancer Research Foundation (BCRF), the foundation's highest scientific honor. The award will be presented at BCRF's annual New York Symposium and Awards Luncheon on Oct. 30.
Vonderheide is the John H. Glick Abramson Cancer Center Professor in the Perelman School of Medicine at the University of Pennsylvania, where he has led the Abramson Cancer Center (ACC) since 2017. An internationally renowned cancer immunotherapy and translational research expert, Vonderheide's research has been supported by BCRF grants since 2007. Through a focus on novel immunotherapies for breast and other cancers, Vonderheide has mapped new models for speeding translational, or "bench to bedside" research.
